AAAAAA

   
Results: 1-25 | 26-50 | 51-64
Results: 1-25/64
NEW APPROACHES TO ANTIFUNGAL CHEMOTHERAPY
Authors: VIVIANI MA DEMARIE S GRAYBILL JR YAMAGUCHI H ANAISSIE E CAILLOT D
Citation: Ma. Viviani et al., NEW APPROACHES TO ANTIFUNGAL CHEMOTHERAPY, MEDICAL MYCOLOGY, 36, 1998, pp. 194-206
THE VALUE OF SURGERY IN THE TREATMENT OF INVASIVE PULMONARY ASPERGILLOSIS IN NEUTROPENIC PATIENTS
Authors: BERNARD A CAILLOT D CASASNOVAS O COUAILLIER JF GUY H FAVRE JP
Citation: A. Bernard et al., THE VALUE OF SURGERY IN THE TREATMENT OF INVASIVE PULMONARY ASPERGILLOSIS IN NEUTROPENIC PATIENTS, Revue des maladies respiratoires, 15(1), 1998, pp. 49-55
DIAGNOSTIC AND THERAPEUTIC STRATEGIES IN THE MANAGEMENT OF NOSOCOMIALPULMONARY ASPERGILLOSIS, IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
Authors: CAILLOT D BERNARD A COUAILLIER JF CASASNOVAS O CUISENIER B MANNONE L LOPEZ J DURAND C BONNIN A PETRELLA T PIARD F DUMAS M GUY H
Citation: D. Caillot et al., DIAGNOSTIC AND THERAPEUTIC STRATEGIES IN THE MANAGEMENT OF NOSOCOMIALPULMONARY ASPERGILLOSIS, IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, Medecine et maladies infectieuses, 28, 1998, pp. 474-484
PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR SYSTEMIC AMYLOIDOSIS (AL) - A REPORT ON 22 CASES
Authors: MOREAU P LEBLOND V BOURQUELOT P FACON T ATTAL M CAILLOT D AUDHUY B NEDELLEC G HUYNH A FERRANT A BATAILLE R HAROUSSEAU JL
Citation: P. Moreau et al., PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY (HDT) AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FOR SYSTEMIC AMYLOIDOSIS (AL) - A REPORT ON 22 CASES, Bone marrow transplantation, 21, 1998, pp. 713-713
BONE-MARROW VERSUS PERIPHERAL-BLOOD VERSUS CD34-CELL FOR AUTOLOGOUS IN MULTIPLE-MYELOMA (MM)( PROGENITORS AS THE SOURCE OF STEM)
Authors: HAROUSSEAU JL ATTAL M PAYEN C FACON T MICHAUX JL GUILHOT F MONCONDUIT M FUZIBET JG CAILLOT D DORVAUX V CAHN JY GROSBOIS B
Citation: Jl. Harousseau et al., BONE-MARROW VERSUS PERIPHERAL-BLOOD VERSUS CD34-CELL FOR AUTOLOGOUS IN MULTIPLE-MYELOMA (MM)( PROGENITORS AS THE SOURCE OF STEM), Bone marrow transplantation, 21, 1998, pp. 714-714
SINGLE VERSUS DOUBLE TRANSPLANT IN MYELOMA - A RANDOMIZED TRIAL OF THE INTER-GROUPE-FRANCAIS-DU-MYELOME (IFM)
Authors: ATTAL M PAYEN C FACON T MICHAUX JL GUILHOT F MOCONDUIT M FUZIBET JG CAILLOT D DORVAUX V HAROUSSEAU JL CAHN JY GROBOIS B STOPPA AM IFRAH N SOTTO JJ PIGNON B BATAILLE R
Citation: M. Attal et al., SINGLE VERSUS DOUBLE TRANSPLANT IN MYELOMA - A RANDOMIZED TRIAL OF THE INTER-GROUPE-FRANCAIS-DU-MYELOME (IFM), Bone marrow transplantation, 21, 1998, pp. 718-718
LOCAL IMMUNOTHERAPY
Authors: MALLING HJ ABREUNOGUEIRA J ALVAREZCUESTA E BJORKSTEN B BOUSQUET J CAILLOT D CANONICA GW PASSALACQUA G SAXONISPAPAGEORGIOU P VALOVIRTA E
Citation: Hj. Malling et al., LOCAL IMMUNOTHERAPY, Allergy, 53(10), 1998, pp. 933-944
QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY
Authors: WATTEL E SOLARY E HECQUET B CAILLOT D IFRAH N BRION A MAHE B MILPIED N JANVIER M GUERCI A ROCHANT H CORDONNIER C DREYFUS F BUZYN A HOANGNGOC L STOPPA AM GRATECOS N SADOUN A STAMATOULAS A TILLY H BRICE P MALOISEL F LIOURE B DESABLENS B PIGNON B ABGRALL JP LEPORRIER M DUPRIEZ B GUYOTAT D LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY, British Journal of Haematology, 102(4), 1998, pp. 1015-1024
BONE-MARROW (BM) VERSUS PERIPHERAL-BLOOD VERSUS CD34-CELL FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)( PROGENITORS AS THE SOURCE OF STEM)
Authors: HAROUSSEAU JL ATTAL M PAYEN C FACON T MICHAUX JL GUILHOT F MONCONDUIT M FUZIBET JG CAILLOT D DORVAUX V CAHN JY GROSBOIS B
Citation: Jl. Harousseau et al., BONE-MARROW (BM) VERSUS PERIPHERAL-BLOOD VERSUS CD34-CELL FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)( PROGENITORS AS THE SOURCE OF STEM), British Journal of Haematology, 102(1), 1998, pp. 6-6
QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY
Authors: WATTEL E SOLARY E HECQUET B CAILLOT D IFRAH N BRION A MILPIED N JANVIER M GUERCI A ROCHANT H CORDONNIER C DREYFUS F VEIL A HOANGNGOC L STOPPA AM GRATECOS N SADOUN A TILLY H BRICE B GUYOTAT D LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY, British Journal of Haematology, 102(1), 1998, pp. 282-282
AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E LELEU X SOLARY E CAILLOT D DREYFUS F BRION A MAHE B JOUET JP HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGUEUX N GUYOTAT D BRICE P LEPELLEY P FENAUX P
Citation: E. Wattel et al., AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), British Journal of Haematology, 102(1), 1998, pp. 320-321
PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN SYSTEMIC AL AMYLOIDOSIS - A REPORT ON 21 PATIENTS
Authors: MOREAU P LEBLOND V BOURQUELOT P FACON T HUYNH A CAILLOT D HERMINE O ATTAL M HAMIDOU M NEDELLEC G FERRANT A AUDHUY B BATAILLE R MILPIED N HAROUSSEAU JL
Citation: P. Moreau et al., PROGNOSTIC FACTORS FOR SURVIVAL AND RESPONSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN SYSTEMIC AL AMYLOIDOSIS - A REPORT ON 21 PATIENTS, British Journal of Haematology, 101(4), 1998, pp. 766-769
INCIDENCE, CLINICAL-FEATURES, AND OUTCOME OF ALL-TRANS-RETINOIC ACID SYNDROME IN 413 CASES OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
Authors: DEBOTTON S DOMBRET H SANZ M SANMIGUEL J CAILLOT D ZITTOUN R GARDEMBAS M STAMATOULAS A CONDE E GUERCI A GARDIN C GEISER K MAKHOUL DC REMAN O DELASERNA J LEFRERE F CHOMIENNE C CHASTANG C DEGOS L FENAUX P
Citation: S. Debotton et al., INCIDENCE, CLINICAL-FEATURES, AND OUTCOME OF ALL-TRANS-RETINOIC ACID SYNDROME IN 413 CASES OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA, Blood, 92(8), 1998, pp. 2712-2718
A PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED DURING AND AFTER INDUCTION TREATMENT FOR DE-NOVO ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS
Authors: WITZ F SADOUN A PERRIN MC BERTHOU C BRIERE J CAHN JY LIOURE B WITZ B FRANCOIS S DESABLENS B PIGNON B LEPRISE PY AUDHUY B CAILLOT D CASASSUS P DELAIN M CHRISTIAN B TELLIER Z POLIN V HURTELOUP P HAROUSSEAU JL
Citation: F. Witz et al., A PLACEBO-CONTROLLED STUDY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTERED DURING AND AFTER INDUCTION TREATMENT FOR DE-NOVO ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS, Blood, 91(8), 1998, pp. 2722-2730
SYSTEMIC MAST-CELL DISEASE-ASSOCIATED WITH HAIRY-CELL LEUKEMIA (VOL 25, PG 593, 1997)
Authors: PETRELLA T DEPRET O ARNOULD L MAYNADIE M GUY H DALAC S CAILLOT D CASASNOVAS O LOMBARD JN
Citation: T. Petrella et al., SYSTEMIC MAST-CELL DISEASE-ASSOCIATED WITH HAIRY-CELL LEUKEMIA (VOL 25, PG 593, 1997), Leukemia & lymphoma, 28(1-2), 1997, pp. 15
SYSTEMIC MAST-CELL DISEASE-ASSOCIATED WITH HAIRY-CELL LEUKEMIA
Authors: PETRELLA T DEPRET O ARNOULD L MAYNADIE M GUY H DALAC S CAILLOT D CASASNOVAS O LOMBARD JN
Citation: T. Petrella et al., SYSTEMIC MAST-CELL DISEASE-ASSOCIATED WITH HAIRY-CELL LEUKEMIA, Leukemia & lymphoma, 25(5-6), 1997, pp. 593-595
TOTAL-BODY IRRADIATION IN THE TREATMENT OF MYELOMA BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
Authors: MAINGON P DHOMBRES A CAILLOT D CASASNOVAS RO HORIOT JC
Citation: P. Maingon et al., TOTAL-BODY IRRADIATION IN THE TREATMENT OF MYELOMA BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT), European journal of cancer, 33, 1997, pp. 448-448
IMPROVED MANAGEMENT OF INVASIVE PULMONARY ASPERGILLOSIS IN NEUTROPENIC PATIENTS USING EARLY THORACIC COMPUTED TOMOGRAPHIC SCAN AND SURGERY
Authors: CAILLOT D CASASNOVAS O BERNARD A COUAILLIER JF DURAND C CUISENIER B SOLARY E PIARD F PETRELLA T BONNIN A COUILLAULT G DUMAS M GUY H
Citation: D. Caillot et al., IMPROVED MANAGEMENT OF INVASIVE PULMONARY ASPERGILLOSIS IN NEUTROPENIC PATIENTS USING EARLY THORACIC COMPUTED TOMOGRAPHIC SCAN AND SURGERY, Journal of clinical oncology, 15(1), 1997, pp. 139-147
INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N IFRAH N ABGRALL JP GUYOTAT D DUPRIEZ B PENY AM BRICE P PIGNON B LEPORRIER M LEPELLEY P FENAUX P
Citation: E. Wattel et al., INTENSIVE CHEMOTHERAPY WITH QUININE IN MYELODYSPLASTIC SYNDROMES (MDS), Experimental hematology, 25(8), 1997, pp. 34-34
HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FORSYSTEMIC AL AMYLOIDOSIS (AL) - A REPORT ON 16 CASES
Authors: MOREAU P FACON T LEBLOND V ATTAL M CAILLOT D NEDELLEC G HUYNH A BATAILLE R HAROUSSEAU JL
Citation: P. Moreau et al., HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) FORSYSTEMIC AL AMYLOIDOSIS (AL) - A REPORT ON 16 CASES, Experimental hematology, 25(8), 1997, pp. 205-205
AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E SOLARY E CAILLOT D DREYFUS F BRION A MAHE B JOUET JP HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGEUX N GUYOTAT D BRICE P LEPELLEY P FENAUX P
Citation: E. Wattel et al., AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), Experimental hematology, 25(8), 1997, pp. 320-320
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST REMISSION - LONG-TERM RESULTS FOR 42 PATIENTS CONDITIONED WITH AN INTENSIFIED REGIMEN (TBI, HIGH-DOSE ARA-C AND MELPHALAN)
Authors: DECONINCK E CAHN JY MILPIED N JOUET JP VERNANT JP ESPEROU H LIOURE B BORDIGONI P LEBLOND V TROUSSARD X CAILLOT D CORDONNIER JM HERVE P
Citation: E. Deconinck et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA IN FIRST REMISSION - LONG-TERM RESULTS FOR 42 PATIENTS CONDITIONED WITH AN INTENSIFIED REGIMEN (TBI, HIGH-DOSE ARA-C AND MELPHALAN), Bone marrow transplantation, 20(9), 1997, pp. 731-735
PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN A MULTIPLE-MYELOMA PATIENT WITH END-STAGE RENAL-FAILURE
Authors: REBIBOU JM CAILLOT D CASASNOVAS RO TANTER Y MAILLARD N SOLARY E RIFLE G GUY H
Citation: Jm. Rebibou et al., PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN A MULTIPLE-MYELOMA PATIENT WITH END-STAGE RENAL-FAILURE, Bone marrow transplantation, 20(1), 1997, pp. 63-65
INVASIVE FUSARIUM INFECTIONS - A RETROSPECTIVE SURVEY OF 31 CASES
Authors: HENNEQUIN C LAVARDE V POIROT JL RABODONIRINA M DATRY A ARACTINGI S DUPOUYCAMET J CAILLOT D GRANGE F KURES L MORIN O LEBEAU B BRETAGNE S GUIGEN C BASSET D GRILLOT R
Citation: C. Hennequin et al., INVASIVE FUSARIUM INFECTIONS - A RETROSPECTIVE SURVEY OF 31 CASES, Journal of medical and veterinary mycology, 35(2), 1997, pp. 107-114
COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA
Authors: HAROUSSEAU JL CAHN JY PIGNON B WITZ F MILPIED N DELAIN M LIOURE B LAMY T DESABLENS B GUILHOT F CAILLOT D ABGRALL JF FRANCOIS S BRIERE J GUYOTAT D CASASSUS P AUDHUY B TELLIER Z HURTELOUP P HERVE P
Citation: Jl. Harousseau et al., COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA, Blood, 90(8), 1997, pp. 2978-2986
Risultati: 1-25 | 26-50 | 51-64